CSCIF (Cosciens Biopharma) Inventory Turnover: 0.91 (As of Mar. 2026)

What is Cosciens Biopharma Inventory Turnover?

Cosciens Biopharma CSCIF +3.90% 60 Inventory Turnover is 0.91 as of Mar. 2026. GuruFocus rates CSCIF with a GF Score™ of 60/100 and a GF Value™ of $2.39 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Cosciens Biopharma's Cost of Goods Sold for the three months ended in Mar. 2026 was $1.10 Mil. Cosciens Biopharma's Average Total Inventories for the quarter that ended in Mar. 2026 was $1.20 Mil. Cosciens Biopharma's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.91.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Cosciens Biopharma's Days Inventory for the three months ended in Mar. 2026 was 100.25.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Cosciens Biopharma's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.64.

Cosciens Biopharma (OTCPK:CSCIF) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Cosciens Biopharma's Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2026 )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
	=	1.203	/	1.095	*	365 / 4
	=	100.25

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Cosciens Biopharma's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	1.203	/	1.888
	=	0.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Cosciens Biopharma Inventory Turnover Related Terms

Cosciens Biopharma Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Cosciens Biopharma's Inventory Turnover can be seen below:

Cosciens Biopharma Inventory Turnover Chart

Cosciens Biopharma Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Inventory Turnover

Get a 7-Day Free Trial

3.81

2.62

1.24

1.45

2.43

Cosciens Biopharma Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Inventory Turnover	Get a 7-Day Free Trial															0.40	0.83	0.48	0.75	0.91

60GF Score

Cosciens Biopharma Inc CSCIF

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Cosciens Biopharma Inventory Turnover Calculation

Cosciens Biopharma's Inventory Turnover for the fiscal year that ended in Dec. 2025 is calculated as

	Inventory Turnover (A: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2025 )	/ (	(Total Inventories (A: Dec. 2024 )	+	Total Inventories (A: Dec. 2025 ))	/	count )
=	4.851	/ (	(2.691	+	1.307)	/	2 )
=	4.851	/	1.999
=	2.43

Cosciens Biopharma's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

	Inventory Turnover (Q: Mar. 2026 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Mar. 2026 )	/ (	(Total Inventories (Q: Dec. 2025 )	+	Total Inventories (Q: Mar. 2026 ))	/	count )
=	1.095	/ (	(1.307	+	1.099)	/	2 )
=	1.095	/	1.203
=	0.91

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 0.91 mean?

Cosciens Biopharma (CSCIF) has a Inventory Turnover of 0.91 as of Mar. 2026. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Cosciens Biopharma and its competitors.

Is Cosciens Biopharma's Inventory Turnover too high?

Cosciens Biopharma's current Inventory Turnover is 0.91. Overall, Cosciens Biopharma has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Cosciens Biopharma's Inventory Turnover compare to VRTX and REGN?

Cosciens Biopharma's Inventory Turnover of 0.91 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Biotechnology company?

A good Inventory Turnover depends on the Biotechnology industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Cosciens Biopharma and its competitors. Cosciens Biopharma's current Inventory Turnover is 0.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Cosciens Biopharma stock overvalued right now?

Based on GuruFocus' analysis, Cosciens Biopharma (CSCIF) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.39, compared to a current price of $2.13 — trading 10.9% below its estimated fair value. The current Inventory Turnover is 0.91. Cosciens Biopharma's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For Cosciens Biopharma (CSCIF), the current Inventory Turnover is 0.91 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cosciens Biopharma (CSCIF) Overvalued in 2026?

Based on GuruFocus' analysis, Cosciens Biopharma stock appears to be undervalued. The current stock price of $2.13 is trading 10.9% below its estimated GF Value™ of $2.39. GuruFocus considers Cosciens Biopharma to be Modestly Undervalued.

Key valuation signals for CSCIF:

Inventory Turnover: 0.91
GF Value™: $2.39 vs. price of $2.13 (10.9% below fair value)
GF Score™: 60/100 with 6 warning signs

No single metric tells the full story. See the CSCIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cosciens Biopharma Business Description

Industry Healthcare Biotechnology

Comparable Companies XCNQ:GLOW TSXV:MRVL XCNQ:BETR TSXV:KNE TSXV:IOT TSXV:HEM TSX:APS XCNQ:PHRM XCNQ:HEAL TSXV:XRTX VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges ET8:Germany CSCI:Canada

Address C/o Borden Ladner Gervais Llp, Suite 3400, 22 Adelaide Street West, Toronto, ON, CAN, M5H 4E3

Website https://www.cosciensbio.com

Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing pharmaceutical and diagnostic products and active ingredients for the healthcare and cosmetics industries. It operates through two segments: Active Ingredient and Biopharmaceutical. The Active Ingredient segment, which generates maximum revenue, focuses on plant-based ingredients derived from oats and other renewable resources, including oat beta glucan, oat oil, and avenanthramides. The Biopharmaceutical segment focuses on the development and commercialization of therapeutics and diagnostic tests, including its product Macrilen, and advancing a pre-clinical pipeline targeting unmet medical needs, particularly in rare or orphan indications. It operates in Canada, Germany, the United States, and Austria.

60GF Score

Get the complete analysis for CSCIF

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.13

Price

$2.39

GF Value

View CSCIF Analysis

See Inventory Turnover data for all stocks →